The modulation of OCT expression in kidney disease is likely of pleiotropic nature and may involve alteration in various protein kinase activity and activation of the ischemia/reperfusion-inducible protein (IRIP) (19–22). The gene discussed is YRDC; the disease is kidney disorder.